Biogen (BIIB) Shares Fall as Guidance Comes In Below Consensus, Analyst Says Focus Remains on Aduhelm Coverage
Go back to Biogen (BIIB) Shares Fall as Guidance Comes In Below Consensus, Analyst Says Focus Remains on Aduhelm Coverage| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 199.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $199.71 | 52 Week High | $333.65 | |||
| Open | $199.71 | 52 Week Low | $223.02 | |||
| Day High | $199.71 | P/E | 25.57 | |||
| Day Low | $199.71 | EPS | $7.81 | |||
| Volume | 2,289 | |||||

